Telix Pharmaceuticals | TLX - Operating Profit

Stock Price
12.41
Daily Change
0.02 0.16%
Monthly
18.98%
Yearly
-55.36%
Q1 Forecast
11.05

Telix Pharmaceuticals reported AUD8.04M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Cochlear AUD 261.1M 135.55M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Integral Diagnostics AUD 19.28M 73.95M Jun/2024
Mayne Pharma AUD -3.3M 15.67M Jun/2024
Medical Developments International AUD -36K 444K Dec/2025
Mesoblast USD -42.11M 21.69M Jun/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
Polynovo AUD 513K 902K Jun/2024
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Ramsay Health Care AUD 541.1M 3.9M Dec/2025
ResMed USD 500.3M 37.95M Dec/2025
Sonic Healthcare AUD 435.76M 193.66M Dec/2024